Novo Nordisk

Business Rebecca Robbins

The insulin market is heading for a shakeup. But patients may not benefit

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Novo Nordisk cutting 1,000 jobs amid diabetes drug price war

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Doctors, investors can’t keep a secret at diabetes meeting

Pharmalot Ed Silverman

A Novo Nordisk diabetes drug may save lives, but Wall Street shrugs